Elevated IL-22 levels have been linked to the pathogenesis of various inflammatory diseases, including psoriasis and inflammatory bowel disease, with IL-22 blockade showing therapeutic promise [9, 10]. This evidence concerns the gene IL22 and inflammatory bowel disease.